{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T04:42:15Z","timestamp":1791175335915,"version":"4.1.0"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2010,8,27]],"date-time":"2010-08-27T00:00:00Z","timestamp":1282867200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1007\/s00259-010-1597-8","type":"journal-article","created":{"date-parts":[[2010,8,26]],"date-time":"2010-08-26T17:32:27Z","timestamp":1282843947000},"page":"108-119","source":"Crossref","is-referenced-by-count":38,"title":["Development of new folate-based PET radiotracers: preclinical evaluation of 68Ga-DOTA-folate conjugates"],"prefix":"10.1007","volume":"38","author":[{"given":"Melpomeni","family":"Fani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Medina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Raynal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Port","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helmut R.","family":"Maecke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2010,8,27]]},"reference":[{"key":"1597_CR1","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1182\/blood.V79.11.2807.2807","volume":"79","author":"AC Antony","year":"1992","unstructured":"Antony AC. The biological chemistry of folate receptors. Blood 1992;79:2807\u201320.","journal-title":"Blood"},{"key":"1597_CR2","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1002\/1097-0142(19940501)73:9<2432::AID-CNCR2820730929>3.0.CO;2-S","volume":"73","author":"JF Ross","year":"1994","unstructured":"Ross JF, Chaudhuri PK, Ratnam M. Differential regulation of folate receptor isoforms in normal and malignant tissues in vivo and in established cell lines. Physiologic and clinical implications. Cancer 1994;73:2432\u201343.","journal-title":"Cancer"},{"key":"1597_CR3","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1146\/annurev.nu.16.070196.002441","volume":"16","author":"AC Antony","year":"1996","unstructured":"Antony AC. Folate receptors. Annu Rev Nutr 1996;16:501\u201321.","journal-title":"Annu Rev Nutr"},{"key":"1597_CR4","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/(SICI)1097-0215(19970422)74:2<193::AID-IJC10>3.0.CO;2-F","volume":"74","author":"G Toffoli","year":"1997","unstructured":"Toffoli G, Cernigoi C, Russo A, Gallo A, Bagnoli M, Boiocchi M. Overexpression of folate binding protein in ovarian cancers. Int J Cancer 1997;74:193\u20138.","journal-title":"Int J Cancer"},{"key":"1597_CR5","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ab.2004.12.026","volume":"338","author":"N Parker","year":"2005","unstructured":"Parker N, Turk MJ, Westrick E, Lewis JD, Low PS, Leamon CP. Folate receptor expression in carcinomas and normal tissues determined by a quantitative radioligand binding assay. Anal Biochem 2005;338:284\u201393.","journal-title":"Anal Biochem"},{"key":"1597_CR6","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1359-6446(00)01594-4","volume":"6","author":"CP Leamon","year":"2001","unstructured":"Leamon CP, Low PS. Folate-mediated targeting: from diagnostics to drug and gene delivery. Drug Discov Today 2001;6:44\u201351.","journal-title":"Drug Discov Today"},{"key":"1597_CR7","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/1389201053642376","volume":"6","author":"JA Reddy","year":"2005","unstructured":"Reddy JA, Allagadda VM, Leamon CP. Targeting therapeutic and imaging agents to folate receptor positive tumors. Curr Pharm Biotechnol 2005;6:131\u201350.","journal-title":"Curr Pharm Biotechnol"},{"key":"1597_CR8","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10555-007-9048-0","volume":"26","author":"MD Salazar","year":"2007","unstructured":"Salazar MD, Ratnam M. The folate receptor: what does it promise in tissue-targeted therapeutics? Cancer Metastasis Rev 2007;26:141\u201352.","journal-title":"Cancer Metastasis Rev"},{"key":"1597_CR9","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1021\/ar7000815","volume":"41","author":"PS Low","year":"2008","unstructured":"Low PS, Henne WA, Doorneweerd DD. Discovery and development of folic-acid-based receptor targeting for imaging and therapy of cancer and inflammatory diseases. Acc Chem Res 2008;41:120\u20139.","journal-title":"Acc Chem Res"},{"key":"1597_CR10","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1073\/pnas.88.13.5572","volume":"88","author":"CP Leamon","year":"1991","unstructured":"Leamon CP, Low PS. Delivery of macromolecules into living cells: a method that exploits folate receptor endocytosis. Proc Natl Acad Sci U S A 1991;88:5572\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1597_CR11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.addr.2004.01.010","volume":"56","author":"S Sabharanjak","year":"2004","unstructured":"Sabharanjak S, Mayor S. Folate receptor endocytosis and trafficking. Adv Drug Deliv Rev 2004;56:1099\u2013109.","journal-title":"Adv Drug Deliv Rev"},{"key":"1597_CR12","first-page":"1563","volume":"40","author":"W Guo","year":"1999","unstructured":"Guo W, Hinkle GH, Lee RJ. 99mTc-HYNIC-folate: a novel receptor-based targeted radiopharmaceutical for tumor imaging. J Nucl Med 1999;40:1563\u20139.","journal-title":"J Nucl Med"},{"key":"1597_CR13","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1021\/bc9901447","volume":"11","author":"CJ Mathias","year":"2000","unstructured":"Mathias CJ, Hubers D, Low PS, Green MA. Synthesis of [(99\u00a0m)Tc]DTPA-folate and its evaluation as a folate-receptor-targeted radiopharmaceutical. Bioconjug Chem 2000;11:253\u20137.","journal-title":"Bioconjug Chem"},{"key":"1597_CR14","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1021\/bc0200430","volume":"13","author":"CP Leamon","year":"2002","unstructured":"Leamon CP, Parker MA, Vlahov IR, Xu LC, Reddy JA, Vetzel M, et al. Synthesis and biological evaluation of EC20: a new folate-derived, (99m)Tc-based radiopharmaceutical. Bioconjug Chem 2002;13:1200\u201310.","journal-title":"Bioconjug Chem"},{"key":"1597_CR15","first-page":"857","volume":"45","author":"JA Reddy","year":"2004","unstructured":"Reddy JA, Xu LC, Parker N, Vetzel M, Leamon CP. Preclinical evaluation of (99m)Tc-EC20 for imaging folate receptor-positive tumors. J Nucl Med 2004;45:857\u201366.","journal-title":"J Nucl Med"},{"key":"1597_CR16","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00259-006-0111-9","volume":"33","author":"C M\u00fcller","year":"2006","unstructured":"M\u00fcller C, Hohn A, Schubiger PA, Schibli R. Preclinical evaluation of novel organometallic 99mTc-folate and 99mTc-pteroate radiotracers for folate receptor-positive tumour targeting. Eur J Nucl Med Mol Imaging 2006;33:1007\u201316.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1597_CR17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.2967\/jnumed.107.045856","volume":"49","author":"C M\u00fcller","year":"2008","unstructured":"M\u00fcller C, Forrer F, Schibli R, Krenning EP, de Jong M. SPECT study of folate receptor-positive malignant and normal tissues in mice using a novel 99mTc-radiofolate. J Nucl Med 2008;49:310\u20137.","journal-title":"J Nucl Med"},{"key":"1597_CR18","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1021\/bc800183r","volume":"19","author":"TL Mindt","year":"2008","unstructured":"Mindt TL, M\u00fcller C, Melis M, de Jong M, Schibli R. \u201cClick-to-chelate\u201d: in vitro and in vivo comparison of a 99mTc(CO)3-labeled N(tau)-histidine folate derivative with its isostructural, clicked 1,2,3-triazole analogue. Bioconjug Chem 2008;19:1689\u201395.","journal-title":"Bioconjug Chem"},{"key":"1597_CR19","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1021\/bc9701297","volume":"8","author":"S Wang","year":"1997","unstructured":"Wang S, Luo J, Lantrip DA, Waters DJ, Mathias CJ, Green MA, et al. Design and synthesis of [111In]DTPA-folate for use as a tumor-targeted radiopharmaceutical. Bioconjug Chem 1997;8:673\u20139.","journal-title":"Bioconjug Chem"},{"key":"1597_CR20","first-page":"1579","volume":"39","author":"CJ Mathias","year":"1998","unstructured":"Mathias CJ, Wang S, Waters DJ, Turek JJ, Low PS, Green MA. Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical. J Nucl Med 1998;39:1579\u201385.","journal-title":"J Nucl Med"},{"key":"1597_CR21","doi-asserted-by":"crossref","first-page":"7421","DOI":"10.1021\/ja043006n","volume":"127","author":"CY Ke","year":"2005","unstructured":"Ke CY, Mathias CJ, Green MA. Targeting the tumor-associated folate receptor with an 111In-DTPA conjugate of pteroic acid. J Am Chem Soc 2005;127:7421\u20136.","journal-title":"J Am Chem Soc"},{"key":"1597_CR22","first-page":"700","volume":"44","author":"BA Siegel","year":"2003","unstructured":"Siegel BA, Dehdashti F, Mutch DG, Podoloff DA, Wendt R, Sutton GP, et al. Evaluation of 111In-DTPA-folate as a receptor-targeted diagnostic agent for ovarian cancer: initial clinical results. J Nucl Med 2003;44:700\u20137.","journal-title":"J Nucl Med"},{"key":"1597_CR23","doi-asserted-by":"crossref","first-page":"899","DOI":"10.2967\/jnumed.107.049478","volume":"49","author":"RE Fisher","year":"2008","unstructured":"Fisher RE, Siegel BA, Edell SL, Oyesiku NM, Morgenstern DE, Messmann RA, et al. Exploratory study of 99mTc-EC20 imaging for identifying patients with folate receptor-positive solid tumors. J Nucl Med 2008;49:899\u2013906.","journal-title":"J Nucl Med"},{"key":"1597_CR24","first-page":"4087","volume":"27","author":"A Al-Nahhas","year":"2007","unstructured":"Al-Nahhas A, Win Z, Szyszko T, Singh A, Nanni C, Fanti S, et al. Gallium-68 PET: a new frontier in receptor cancer imaging. Anticancer Res 2007;27:4087\u201394.","journal-title":"Anticancer Res"},{"key":"1597_CR25","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/cmmi.232","volume":"3","author":"M Fani","year":"2008","unstructured":"Fani M, Andr\u00e9 JP, Maecke HR. 68Ga-PET: a powerful generator-based alternative to cyclotron-based PET radiopharmaceuticals. Contrast Media Mol Imaging 2008;3:67\u201377.","journal-title":"Contrast Media Mol Imaging"},{"key":"1597_CR26","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1021\/bc9500709","volume":"7","author":"S Wang","year":"1996","unstructured":"Wang S, Lee RJ, Mathias CJ, Green MA, Low PS. Synthesis, purification, and tumor cell uptake of 67Ga-deferoxamine\u2013folate, a potential radiopharmaceutical for tumor imaging. Bioconjug Chem 1996;7:56\u201362.","journal-title":"Bioconjug Chem"},{"key":"1597_CR27","first-page":"1003","volume":"37","author":"CJ Mathias","year":"1996","unstructured":"Mathias CJ, Wang S, Lee RJ, Waters DJ, Low PS, Green MA. Tumor-selective radiopharmaceutical targeting via receptor-mediated endocytosis of gallium-67-deferoxamine-folate. J Nucl Med 1996;37:1003\u20138.","journal-title":"J Nucl Med"},{"key":"1597_CR28","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0969-8051(98)00076-6","volume":"26","author":"CJ Mathias","year":"1999","unstructured":"Mathias CJ, Wang S, Low PS, Waters DJ, Green MA. Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts. Nucl Med Biol 1999;26:23\u20135.","journal-title":"Nucl Med Biol"},{"key":"1597_CR29","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S0969-8051(03)00080-5","volume":"30","author":"CJ Mathias","year":"2003","unstructured":"Mathias CJ, Lewis MR, Reichert DE, Laforest R, Sharp TL, Lewis JS, et al. Preparation of 66Ga- and 68Ga-labeled Ga(III)-deferoxamine-folate as potential folate-receptor-targeted PET radiopharmaceuticals. Nucl Med Biol 2003;30:725\u201331.","journal-title":"Nucl Med Biol"},{"key":"1597_CR30","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1007\/s00259-006-0118-2","volume":"33","author":"C M\u00fcller","year":"2006","unstructured":"M\u00fcller C, Schubiger PA, Schibli R. In vitro and in vivo targeting of different folate receptor-positive cancer cell lines with a novel 99mTc-radiofolate tracer. Eur J Nucl Med Mol Imaging 2006;33:1162\u201370.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1597_CR31","first-page":"5329","volume":"51","author":"IG Campbell","year":"1991","unstructured":"Campbell IG, Jones TA, Foulkes WD, Trowsdale J. Folate-binding protein is a marker for ovarian cancer. Cancer Res 1991;51:5329\u201338.","journal-title":"Cancer Res"},{"key":"1597_CR32","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2967\/jnumed.107.040378","volume":"48","author":"KP Zhernosekov","year":"2007","unstructured":"Zhernosekov KP, Filosofov DV, Baum RP, Aschoff P, Bihl H, Razbash AA, et al. Processing of generator-produced 68Ga for medical application. J Nucl Med 2007;48:1741\u20138.","journal-title":"J Nucl Med"},{"key":"1597_CR33","doi-asserted-by":"crossref","first-page":"13","DOI":"10.4137\/DTI.S651","volume":"3","author":"N Viola-Villegas","year":"2008","unstructured":"Viola-Villegas N, Vortherms A, Doyle RP. Targeting gallium to cancer cells through the folate receptor. Drug Target Insights 2008;3:13\u201325.","journal-title":"Drug Target Insights"},{"key":"1597_CR34","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1021\/bc800356r","volume":"19","author":"TL Ross","year":"2008","unstructured":"Ross TL, Honer M, Lam PY, Mindt TL, Groehn V, Schibli R, et al. Fluorine-18 click radiosynthesis and preclinical evaluation of a new 18F-labeled folic acid derivative. Bioconjug Chem 2008;19:2462\u201370.","journal-title":"Bioconjug Chem"},{"key":"1597_CR35","doi-asserted-by":"crossref","first-page":"623","DOI":"10.2967\/jnumed.107.047704","volume":"49","author":"C M\u00fcller","year":"2008","unstructured":"M\u00fcller C, Schibli R, Krenning EP, de Jong M. Pemetrexed improves tumor selectivity of 111In-DTPA-folate in mice with folate receptor-positive ovarian cancer. J Nucl Med 2008;49:623\u20139.","journal-title":"J Nucl Med"},{"key":"1597_CR36","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1124\/mol.104.003723","volume":"66","author":"CM Paulos","year":"2004","unstructured":"Paulos CM, Reddy JA, Leamon CP, Turk MJ, Low PS. Ligand binding and kinetics of folate receptor recycling in vivo: impact on receptor-mediated drug delivery. Mol Pharmacol 2004;66:1406\u201314.","journal-title":"Mol Pharmacol"},{"key":"1597_CR37","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1158\/1078-0432.CCR-07-1687","volume":"14","author":"M Ginj","year":"2008","unstructured":"Ginj M, Zhang H, Eisenwiener KP, Wild D, Schulz S, Rink H, et al. New pansomatostatin ligands and their chelated versions: affinity profile, agonist activity, internalization, and tumor targeting. Clin Cancer Res 2008;14:2019\u201327.","journal-title":"Clin Cancer Res"},{"key":"1597_CR38","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1007\/s00259-008-1058-9","volume":"36","author":"C M\u00fcller","year":"2009","unstructured":"M\u00fcller C, Mindt TL, de Jong M, Schibli R. Evaluation of a novel radiofolate in tumour-bearing mice: promising prospects for folate-based radionuclide therapy. Eur J Nucl Med Mol Imaging 2009;36:938\u201346.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"1597_CR39","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/S0969-8043(97)10107-5","volume":"49","author":"C Caraco","year":"1998","unstructured":"Caraco C, Aloj L, Eckelman WC. The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions. Appl Radiat Isot 1998;49:1477\u20139.","journal-title":"Appl Radiat Isot"},{"key":"1597_CR40","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1007\/s10555-008-9155-6","volume":"27","author":"EI Sega","year":"2008","unstructured":"Sega EI, Low PS. Tumor detection using folate receptor-targeted imaging agents. Cancer Metastasis Rev 2008;27:655\u201364.","journal-title":"Cancer Metastasis Rev"},{"key":"1597_CR41","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.nucmedbio.2007.12.008","volume":"35","author":"PM Smith-Jones","year":"2008","unstructured":"Smith-Jones PM, Pandit-Taskar N, Cao W, O\u2019Donoghue J, Philips MD, Carrasquillo J, et al. Preclinical radioimmunotargeting of folate receptor alpha using the monoclonal antibody conjugate DOTA-MORAb-003. Nucl Med Biol 2008;35:343\u201351.","journal-title":"Nucl Med Biol"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1597-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-010-1597-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-010-1597-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,10]],"date-time":"2020-06-10T23:51:57Z","timestamp":1591833117000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-010-1597-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,8,27]]},"references-count":41,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011,1]]}},"alternative-id":["1597"],"URL":"https:\/\/doi.org\/10.1007\/s00259-010-1597-8","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,8,27]]}}}